Loading clinical trials...

Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss | Clinical Trials | Clareo Health

COMPLETEDPHASE2

Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss

Efficacy of Therapy With the Anti-androgen Spironolactone Compared to Topical Minoxidil in Female Pattern Hair Loss

NCT00175617•University of British Columbia

View on ClinicalTrials.gov

Summary

This study evaluates the efficacy of therapy with the anti-androgen spironolactone compared to topical minoxidil in female pattern hair loss.

Eligibility

Age

18 - 75 years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•Subjects must be premenopausal women older than 18 with female pattern hair loss.

Exclusion Criteria

•Androgen excess
•Other scalp or hair disorders
•Contraindications to spironolactone treatment, especially pregnancy, electrolyte imbalances, history of breast cancer, or intake of interfering drugs
•Contraindications to minoxidil treatment, especially patients who are allergic to this treatment or have a history of low blood pressure or irregular heart beats

Locations (1)

UBC Division of Dermatology, Hair Research and Treatment Centre

Vancouver, British Columbia, Canada

Key Dates

Start Date

September 1, 2005

Primary Completion Date

March 9, 2009

Completion Date

March 9, 2009

Last Updated

March 3, 2017

Enrollment

ESTIMATED participants

Conditions

Female Pattern Hair Loss

Interventions

Spironolactone

DRUG

Minoxidil

DRUG

Clinical Evaluation of a Nutraceutical Supplement for Hair Growth, Hair Loss and Skin Improvement in Human Volunteers Versus Placebo

NCT07111299

Early Female Pattern Hair Loss (FPHL)

View study

COMPLETEDNA

Successful Treatment of Female Pattern Hair Loss With Injection of Nanofat With and Without Platelet-Rich Plasma

NCT07096323

Female Pattern Hair Loss

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 3, 2017Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions